Cargando…
Morbihan disease: a therapeutic challenge
Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractori...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786404/ https://www.ncbi.nlm.nih.gov/pubmed/29364446 http://dx.doi.org/10.1590/abd1806-4841.20174485 |
_version_ | 1783295780499488768 |
---|---|
author | Cabral, Fernanda Lubbe, Lara Caroline Nóbrega, Monisa Martins Obadia, Daniel Lago Souto, Roberto Gripp, Alexandre Carlos |
author_facet | Cabral, Fernanda Lubbe, Lara Caroline Nóbrega, Monisa Martins Obadia, Daniel Lago Souto, Roberto Gripp, Alexandre Carlos |
author_sort | Cabral, Fernanda |
collection | PubMed |
description | Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease, who showed excellent therapeutic response with the combination of deflazacort and oral isotretinoin but developed recurrence after corticosteroid discontinuation. We believe that in severe cases of lymphedema of the face this combination is effective and corticosteroid suspension should be done slowly and gradually. |
format | Online Article Text |
id | pubmed-5786404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Sociedade Brasileira de Dermatologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-57864042018-02-01 Morbihan disease: a therapeutic challenge Cabral, Fernanda Lubbe, Lara Caroline Nóbrega, Monisa Martins Obadia, Daniel Lago Souto, Roberto Gripp, Alexandre Carlos An Bras Dermatol Case Report Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease, who showed excellent therapeutic response with the combination of deflazacort and oral isotretinoin but developed recurrence after corticosteroid discontinuation. We believe that in severe cases of lymphedema of the face this combination is effective and corticosteroid suspension should be done slowly and gradually. Sociedade Brasileira de Dermatologia 2017 /pmc/articles/PMC5786404/ /pubmed/29364446 http://dx.doi.org/10.1590/abd1806-4841.20174485 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way. |
spellingShingle | Case Report Cabral, Fernanda Lubbe, Lara Caroline Nóbrega, Monisa Martins Obadia, Daniel Lago Souto, Roberto Gripp, Alexandre Carlos Morbihan disease: a therapeutic challenge |
title | Morbihan disease: a therapeutic challenge |
title_full | Morbihan disease: a therapeutic challenge |
title_fullStr | Morbihan disease: a therapeutic challenge |
title_full_unstemmed | Morbihan disease: a therapeutic challenge |
title_short | Morbihan disease: a therapeutic challenge |
title_sort | morbihan disease: a therapeutic challenge |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786404/ https://www.ncbi.nlm.nih.gov/pubmed/29364446 http://dx.doi.org/10.1590/abd1806-4841.20174485 |
work_keys_str_mv | AT cabralfernanda morbihandiseaseatherapeuticchallenge AT lubbelaracaroline morbihandiseaseatherapeuticchallenge AT nobregamonisamartins morbihandiseaseatherapeuticchallenge AT obadiadaniellago morbihandiseaseatherapeuticchallenge AT soutoroberto morbihandiseaseatherapeuticchallenge AT grippalexandrecarlos morbihandiseaseatherapeuticchallenge |